about
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.Allogeneic stem cell transplantation in a blast-phase chronic myeloid leukemia patient with carbapenem-resistant Klebsiella pneumoniae tricuspid valve endocarditis: A case report.Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemiaTreatment and outcome of 2904 CML patients from the EUTOS population-based registry.Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations."Chronic myelogenous leukemia in primary blast crisis" rather than "de novo BCR-ABL1-positive acute myeloid leukemia".Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist's Point of View
P2860
Q30242015-45262336-3C49-4234-90AF-DAA638D190A1Q33442587-48F59355-8F2E-459F-8275-8280D73ACCC8Q36188696-1955D39A-566E-4957-B979-9321F280B1CCQ37288234-FB2886E6-B8BA-438A-97CC-9B51FB6AC4CEQ37423508-A8EE2733-EDC2-433C-8EAB-9E6B4220A753Q37744812-C27EDD97-EF51-4FA0-8ED6-EDF0E847C811Q39446340-39BB7964-54DA-4F02-BA53-5552A1CDE8AEQ39591396-082E3D8B-BBE3-48F9-B046-5A41DE7F26CDQ40607863-BF1D5ADF-FDE0-46EC-9167-E15B358DFE46Q41282875-0D76DA7F-7B31-40B6-9E55-3A56FE23F86CQ41878295-918132E9-B0BE-45E1-82DC-858EC782ADBBQ42650776-71E5B02A-7D28-4C40-86EF-F88514F80FB7Q49593223-6F764419-227F-4D9E-A08A-2B4FE9DF1C4DQ57493092-B8CA5E1D-25FB-47D3-80D5-8698EB3EE734
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of chronic myeloid leukemia in blast crisis.
@en
type
label
Management of chronic myeloid leukemia in blast crisis.
@en
prefLabel
Management of chronic myeloid leukemia in blast crisis.
@en
P2860
P1433
P1476
Management of chronic myeloid leukemia in blast crisis.
@en
P2093
Richard T Silver
P2860
P304
P356
10.1007/S00277-015-2324-0
P478
94 Suppl 2
P577
2015-03-27T00:00:00Z